Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review. - Wikidata - awgldk - TriplyDB

Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review.

Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review.

http://www.wikidata.org/entity/Q37577551

about

Alpha-fetoprotein-targeted reporter gene expression imaging in hepatocellular carcinoma Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.Diagnostic Value of Serum Level of Soluble Tumor Necrosis Factor Receptor IIα in Egyptian Patients With Chronic Hepatitis C Virus Infection and Hepatocellular Carcinoma.Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.Elevated serum alpha fetoprotein levels promote pathological progression of hepatocellular carcinoma.Rapid and early α-fetoprotein and des-γ-carboxy prothrombin responses to initial arterial infusion chemotherapy predict treatment outcomes of advanced hepatocellular carcinoma.Performance of Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II) for Hepatocellular Carcinoma Screening in Chinese Population.Serum Alpha-Fetoprotein Has High Specificity for the Early Detection of Hepatocellular Carcinoma After Hepatitis C Virus Eradication in Patients Des-γ-Carboxyprothrombin Plasma Level in Diagnosis of Hepatocellular Carcinoma in a Chinese Population Undergoing Surgery.Different Nodules Identified during Liver Explant Gross Examination: Relevance and Need for Sectioning-Experience from India.Efficacy of PIVKA-II in prediction and early detection of hepatocellular carcinoma: a nested case-control study in Chinese patients.Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy.Circulating microRNA profiles in plasma: identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function.Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications Cancer biomarkers for hepatocellular carcinomas: from traditional markers to recent topics.Diagnostic accuracy of des-gamma-carboxy prothrombin versus α-fetoprotein for hepatocellular carcinoma: A systematic review.PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients.Tumour-associated antigens and their anti-cancer applications.Disease monitoring of hepatocellular carcinoma through metabolomics.Alpha fetoprotein mediates HBx induced carcinogenesis in the hepatocyte cytoplasm.Artificial neural networking model for the prediction of post-hepatectomy survival of patients with early hepatocellular carcinoma.Phenotype-dependent production of des-γ-carboxy prothrombin in hepatocellular carcinoma.Clinical significance of the highly sensitive fucosylated fraction of α-fetoprotein in patients with chronic liver disease.Des-γ carboxyprothrombin may not be a good biomarker for hepatocellular carcinoma in those chronically infected with hepatitis B virus with basal core promoter double mutations (T^{1762}, A^{1764}), a prospective study.Biomarkers: evaluation of clinical utility in surveillance and early diagnosis for hepatocellular carcinoma.Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.Circulating microRNA, miR-122 and miR-221 signature in Egyptian patients with chronic hepatitis C related hepatocellular carcinoma.Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.A long-term follow-up and comprehensive observation of risk and prognosis factors of recurrence and survival after resection of hepatocellular carcinoma.Plasma Heat Shock Protein 90alpha as a Biomarker for the Diagnosis of Liver Cancer: An Official, Large-scale, and Multicenter Clinical Trial.The 4th Asia-Pacific Primary Liver Cancer Expert Meeting Combined low miRNA-29s is an independent risk factor in predicting prognosis of patients with hepatocellular carcinoma after hepatectomy: A Chinese population-based study.Serum microRNA signatures and metabolomics have high diagnostic value in hepatocellular carcinoma.Prognostic values of long non-coding RNA MIR22HG for patients with hepatocellular carcinoma after hepatectomy.A novel and validated prognostic nomogram based on liver fibrosis and tumor burden for patients with hepatocellular carcinoma after curative resection.Should AFP (or any biomarkers) be used for HCC surveillance?Outcome of hypovascular hepatic nodules with positive uptake of gadoxetic acid in patients with cirrhosis.

P2860

Q26741197-F6680365-9E53-4F57-9FEC-27F989890D6E Q26772324-A2EAE18E-BA85-44A4-AA0A-C62D0F6F0DD4 Q30479629-51BB1100-B953-4BD8-AB56-1537AABB23FD Q34461237-0FBE8EB4-6F6F-401F-A67A-094AA4149D9D Q35534064-BE660BA3-16CA-4E6E-8E51-25B66ED4E0CB Q35581398-262EBCF2-0471-4BBC-9361-DFE33CCAE007 Q35753801-A7459179-36E9-4F61-9030-8FC5AC703B22 Q35964785-C71322F9-2467-4D59-B9EB-81A198C1C082 Q36194266-5B93E7CB-477D-4115-8594-16BB48A78A43 Q37020982-31A6176A-57C5-4161-A4C9-35C23377A069 Q37067542-002D73B4-A367-405D-B543-0086A89152F8 Q37330554-4CD7D5B5-3892-4BD9-A8BA-E1D3C5D828CC Q37351966-D3DAB318-AEA0-4958-8D5C-C63F70D420B2 Q37619833-8D02149F-0A55-4C25-967A-FB7C6AB322A3 Q37706763-3B65E392-1456-402F-B87B-A29DEA33783E Q37856310-7A8CE494-4091-4CB0-BF04-A8BAAC43B6AB Q38120063-29ADB3B1-B1CF-4B8F-BC28-B3F302CECE14 Q38704682-B90A0C9E-DE50-45A6-9B02-4A2FF87B6A4D Q38725552-2EB7C374-D9F5-4A53-943D-1BA4834BE230 Q38768256-BC9E524A-260C-4FA4-874C-4DD6975C546E Q38890467-19063329-B666-4A23-BD11-92345221A91A Q39165780-9B8026ED-AD00-439C-BB6D-348333B78ADF Q39509223-C861DD29-36FA-4805-991C-1B635F23B4DB Q39816294-7AB54E61-129D-4DB8-A163-0858C94E7643 Q40373005-E10D30F3-5D2D-4331-9265-FD641183ED39 Q40606533-F4C03482-44A5-4C76-9445-6F7455AB567A Q41183184-F1195F8A-2C36-4D4F-84BE-132C1D9C8E07 Q41505555-83911615-9AD3-4B7C-911B-743C4CD89C8C Q41921235-A2787B6F-3BBC-460F-88CF-999C0E203F43 Q41921861-63607C1C-786E-45A7-B10C-15F2098AF401 Q41962614-0F39E62E-637A-4D04-B36E-4EA43F8D71BB Q42224788-B1EB0478-9FD2-49E5-96C2-F236B8E4B037 Q42651973-A57B3992-0E99-4C18-AB7D-D4EF55823323 Q47121517-7F39F5E8-55A0-4921-BC12-7B8ABCDBCF84 Q47146281-746D1F93-CC34-4E6C-B09C-8C79CB69FB79 Q47220534-38FE833A-E33E-4FAF-A872-18F9CA1698C0 Q47548935-A2DB03BF-5DF3-4166-A8FF-F0FC4F2DB10D Q49806650-3F567930-5CF9-44C2-9190-531589299170 Q50223186-3BDBC5F3-ABE9-492F-B507-D75B221217B7 Q53089913-E0BE209C-76D9-490A-B67D-D41C1ACD3114

P2860

Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review.

http://www.wikidata.org/entity/Q37577551

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 December 2007

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review.

@en

Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review.

@nl

type

label

Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review.

@en

Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review.

@nl

prefLabel

Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review.

@en

Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review.

@nl

P1433

Q37577551-67B6DB4D-3C0D-421C-9070-CD5D4429ACDF

P1476

Q37577551-50EB1776-AA90-483E-8BFB-2B4A499A1032

P2093

Q37577551-211698FB-FBCE-46F2-83CE-FA36D4E39022

Q37577551-26964D12-6DDD-40D7-BBC6-946DACEEDC2F

Q37577551-7EE1257D-2856-4CC4-817E-A60FFC186999

Q37577551-98D0E669-1827-4643-AC9A-B36275DC100B

Q37577551-CA7D9207-4FFD-4796-AC2D-0CB482F45267

P2860

Q37577551-04351347-46AC-41D5-91E9-6620BE36EEA1

Q37577551-099962BD-D7EF-4C93-92FA-918E73C3D3F8

Q37577551-1387F253-0368-4D69-871E-F06DB7E35F55

Q37577551-14ECEF73-F80E-4801-9DB2-191D6802D95C

Q37577551-1A4C706A-AC06-4274-B17F-799E147722FE

Q37577551-1C68A8A8-A3F8-44A8-885D-3E878E9D1653

Q37577551-1C757EDC-21E4-4319-B186-603B8BB9C23E

Q37577551-1CCEB9B5-E770-4896-99A6-3DED45D06EE9

Q37577551-2158C146-F31C-48E1-BEFF-B266BE48EB30

Q37577551-2BC92DC9-11E6-4BF7-8E88-E2E6084BA6E9

P2888

Q37577551-8A8144E2-46AF-49A9-BFD9-4579FDCBB069

P304

Q37577551-F5755B40-0D6C-4490-988E-794E4EC27BB2

P31

Q37577551-8ACDAC45-8A17-4D99-8181-18A9B847331A

P356

Q37577551-537003FB-56EC-4F48-AFDB-597A694507C8

P433

Q37577551-D7EB6F25-1E63-4858-AB0D-6904B873891B

P478

Q37577551-4A70F0BC-EE36-4AD4-8E95-A2D32D3861A6

P50

Q37577551-68BFD51D-9728-4886-8212-900C7EE65704

P577

Q37577551-F552A97B-21D3-4E86-881D-1B96BD298804

P5875

Q37577551-09BBF986-8B36-41BC-A2E9-E519980B8B5E

P698

Q37577551-03022799-8359-4B5B-B630-45532BD4E4D8

P921

Q37577551-73d32f6c-4b8a-47fe-b008-85f11ebd5671

P932

Q37577551-2FEF83FD-DBC4-4749-878A-ED92CB86DC6D

P356

S12072-007-9038-X

P1433

Hepatology international

P1476

Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review

@en

P2093

Haruhiko Yoshida

http://www.w3.org/2001/XMLSchema#string

Masao Omata

http://www.w3.org/2001/XMLSchema#string

Norio Mine

http://www.w3.org/2001/XMLSchema#string

Yuji Kondo

http://www.w3.org/2001/XMLSchema#string

Yutaka Matsuyama

http://www.w3.org/2001/XMLSchema#string

P2860

Bias in meta-analysis detected by a simple, graphical test

Meta-analysis in clinical trials

Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma

Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma

Management of hepatocellular carcinoma

Primary liver cancer: worldwide incidence and trends

Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data.

Empirical evidence of design-related bias in studies of diagnostic tests.

Meta-DiSc: a software for meta-analysis of test accuracy data.

Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients.

P2888

s12072-007-9038-x

P304

17-30

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12072-007-9038-X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Ryosuke Tateishi

P577

2007-12-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26730842

http://www.w3.org/2001/XMLSchema#string

P698

19669276

http://www.w3.org/2001/XMLSchema#string

P921

P932

2716871

http://www.w3.org/2001/XMLSchema#string